MARKET

RNAZ

RNAZ

Transcode Therapeutics Inc
NASDAQ
3.430
-0.450
-11.60%
Pre Market: 3.820 +0.39 +11.37% 09:21 08/12 EDT
OPEN
3.900
PREV CLOSE
3.880
HIGH
3.980
LOW
3.430
VOLUME
1.01K
TURNOVER
123.19K
52 WEEK HIGH
20.99
52 WEEK LOW
3.430
MARKET CAP
10.35M
P/E (TTM)
-0.0704
1D
5D
1M
3M
1Y
5Y
1D
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 3h ago
Weekly Report: what happened at RNAZ last week (0803-0807)?
Weekly Report · 2d ago
Virax Biolabs and Transcode Therapeutics Interviews to Air Nationally on the RedChip Small Stocks, Big Money(TM) Show on CNBC and Bloomberg TV
Barchart · 5d ago
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 08/03 21:05
TransCode Therapeutics Updates Preferred Stock Governance Terms
TipRanks · 08/03 21:02
Weekly Report: what happened at RNAZ last week (0727-0731)?
Weekly Report · 08/03 09:21
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 07/29 21:06
Weekly Report: what happened at RNAZ last week (0720-0724)?
Weekly Report · 07/27 09:22
More
About RNAZ
TransCode Therapeutics, Inc. is a clinical-stage oncology company focused on treating metastatic disease. It is defeating cancer through the intelligent design and effective delivery of RNA therapeutics based on its proprietary TTX nanoparticle platform. Its lead candidate, TTX-MC138, targets metastatic tumors overexpressing microRNA-10b, a biomarker of metastasis. The Company is also developing a portfolio of RNA therapeutic candidates to overcome delivery challenges and unlock access to novel genetic targets. Its preclinical programs include TTX-siPDL1 (siRNA modulator of PD-L1), TTX-RIGA (RNA agonist of RIG-I for innate immunity activation), and TTX-siMYC (siRNA inhibitor of c-MYC). Additionally, R&D efforts are exploring the combination of TTX-MC138 and seviprotimut-L technologies to enhance therapeutic impact.

Webull offers Transcode Therapeutics Inc stock information, including NASDAQ: RNAZ real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, RNAZ stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading RNAZ stock methods without spending real money on the virtual paper trading platform.